ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
152 hedge funds and large institutions have $1.57B invested in Acorda Therapeutics in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 57 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
28% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 32
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
152
Holding in Top 10
1
Calls
$2.9M
Puts
$1.97M
Top Buyers
| 1 | +$37.9M | |
| 2 | +$27.4M | |
| 3 | +$25M | |
| 4 |
PC
PointState Capital
New York
|
+$19M |
| 5 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$12.9M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$13.3M | |
| 3 | -$12.8M | |
| 4 |
HM
HealthCor Management
New York
|
-$11.7M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$11.5M |